Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0JPBSV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Tras.D221N-MMAF (HEK GDLN)
|
|||||
| Synonyms |
Tras.D221N-MMAF (HEK GDLN)
Click to Show/Hide
|
|||||
| Organization |
VIB VZW | UNIVERSITEIT GENT
|
|||||
| Drug Status |
Investigative
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin F
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
a glycan-based conjugation extension of the GlycoDelete technology
|
|||||
| Combination Type |
D221N-MMAF (HEK GDLN)
|
|||||